276 related articles for article (PubMed ID: 33183344)
21. Changes in anti-citrullinated protein antibody isotype levels in relation to disease activity and response to treatment in early rheumatoid arthritis.
Kastbom A; Roos Ljungberg K; Ziegelasch M; Wetterö J; Skogh T; Martinsson K
Clin Exp Immunol; 2018 Dec; 194(3):391-399. PubMed ID: 30136282
[TBL] [Abstract][Full Text] [Related]
22. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
[TBL] [Abstract][Full Text] [Related]
23. Persistence of Disease-Associated Anti-Citrullinated Protein Antibody-Expressing Memory B Cells in Rheumatoid Arthritis in Clinical Remission.
Pelzek AJ; Grönwall C; Rosenthal P; Greenberg JD; McGeachy M; Moreland L; Rigby WFC; Silverman GJ
Arthritis Rheumatol; 2017 Jun; 69(6):1176-1186. PubMed ID: 28118534
[TBL] [Abstract][Full Text] [Related]
24. Circulating anti-citrullinated protein antibodies containing secretory component are prognostic for arthritis onset in at-risk patients.
Roos Ljungberg K; Martinsson K; Wetterö J; Svärd A; Kastbom A
Clin Exp Immunol; 2021 Jun; 204(3):344-351. PubMed ID: 33675063
[TBL] [Abstract][Full Text] [Related]
25. A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and the effectiveness of abatacept in rheumatoid arthritis patients.
Kida D; Takahashi N; Kaneko A; Hirano Y; Fujibayashi T; Kanayama Y; Hanabayashi M; Yabe Y; Takagi H; Oguchi T; Kato T; Funahashi K; Matsumoto T; Ando M; Kuwatsuka Y; Tanaka E; Yasuoka H; Kaneko Y; Hirata S; Murakami K; Sobue Y; Nishiume T; Suzuki M; Yokota Y; Terabe K; Asai S; Ishiguro N; Kojima T
Sci Rep; 2020 Nov; 10(1):19717. PubMed ID: 33184461
[TBL] [Abstract][Full Text] [Related]
26. Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis.
Katchamart W; Koolvisoot A; Aromdee E; Chiowchanwesawakit P; Muengchan C
Rheumatol Int; 2015 Oct; 35(10):1693-9. PubMed ID: 25903353
[TBL] [Abstract][Full Text] [Related]
27. Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies.
Reed E; Jiang X; Kharlamova N; Ytterberg AJ; Catrina AI; Israelsson L; Mathsson-Alm L; Hansson M; Alfredsson L; Rönnelid J; Lundberg K
Arthritis Res Ther; 2016 May; 18(1):96. PubMed ID: 27145822
[TBL] [Abstract][Full Text] [Related]
28. [The pathogenic role of ACPA in rheumatoid arthritis].
Umeda N; Matsumoto I; Sumida T
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):391-395. PubMed ID: 29367523
[TBL] [Abstract][Full Text] [Related]
29. Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis.
Vander Cruyssen B; Nogueira L; Van Praet J; Deforce D; Elewaut D; Serre G; De Keyser F
Ann Rheum Dis; 2008 Apr; 67(4):542-6. PubMed ID: 17644546
[TBL] [Abstract][Full Text] [Related]
30.
Hiwa R; Ikari K; Ohmura K; Nakabo S; Matsuo K; Saji H; Yurugi K; Miura Y; Maekawa T; Taniguchi A; Yamanaka H; Matsuda F; Mimori T; Terao C
J Rheumatol; 2018 Apr; 45(4):470-480. PubMed ID: 29419463
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort.
Nicaise-Roland P; Nogueira L; Demattei C; de Chaisemartin L; Rincheval N; Cornillet M; Grootenboer-Mignot S; Dieudé P; Dougados M; Cantagrel A; Meyer O; Serre G; Chollet-Martin S
Ann Rheum Dis; 2013 Mar; 72(3):357-62. PubMed ID: 22580581
[TBL] [Abstract][Full Text] [Related]
32. Differential responsiveness to immunoablative therapy in refractory rheumatoid arthritis is associated with level and avidity of anti-cyclic citrullinated protein autoantibodies: a case study.
Teng YK; Verburg RJ; Verpoort KN; Diepenhorst GM; Bajema IM; van Tol MJ; Jol-van der Zijde EC; Toes RE; Huizinga TW; van Laar JM
Arthritis Res Ther; 2007; 9(5):R106. PubMed ID: 17927821
[TBL] [Abstract][Full Text] [Related]
33. The use of synthetic peptides for detection of anti-citrullinated protein antibodies in rheumatoid arthritis.
Trier NH; Holm BE; Heiden J; Slot O; Locht H; Jensen B; Lindegaard H; Svendsen A; Nielsen CT; Jacobsen S; Theander E; Houen G
J Immunol Methods; 2018 Mar; 454():6-14. PubMed ID: 29128424
[TBL] [Abstract][Full Text] [Related]
34. Affinity Maturation of the Anti-Citrullinated Protein Antibody Paratope Drives Epitope Spreading and Polyreactivity in Rheumatoid Arthritis.
Kongpachith S; Lingampalli N; Ju CH; Blum LK; Lu DR; Elliott SE; Mao R; Robinson WH
Arthritis Rheumatol; 2019 Apr; 71(4):507-517. PubMed ID: 30811898
[TBL] [Abstract][Full Text] [Related]
35. N-Linked Glycans in the Variable Domain of IgG Anti-Citrullinated Protein Antibodies Predict the Development of Rheumatoid Arthritis.
Hafkenscheid L; de Moel E; Smolik I; Tanner S; Meng X; Jansen BC; Bondt A; Wuhrer M; Huizinga TWJ; Toes REM; El-Gabalawy H; Scherer HU
Arthritis Rheumatol; 2019 Oct; 71(10):1626-1633. PubMed ID: 31067000
[TBL] [Abstract][Full Text] [Related]
36. Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology.
Sherina N; Hreggvidsdottir HS; Bengtsson C; Hansson M; Israelsson L; Alfredsson L; Lundberg K
Arthritis Res Ther; 2017 Sep; 19(1):219. PubMed ID: 28962582
[TBL] [Abstract][Full Text] [Related]
37. Association of anti-citrullinated protein or peptide antibodies with left ventricular structure and function in rheumatoid arthritis.
Geraldino-Pardilla L; Russo C; Sokolove J; Robinson WH; Zartoshti A; Van Eyk J; Fert-Bober J; Lima J; Giles JT; Bathon JM
Rheumatology (Oxford); 2017 Apr; 56(4):534-540. PubMed ID: 27994093
[TBL] [Abstract][Full Text] [Related]
38. Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis.
Szodoray P; Szabó Z; Kapitány A; Gyetvai A; Lakos G; Szántó S; Szücs G; Szekanecz Z
Autoimmun Rev; 2010 Jan; 9(3):140-3. PubMed ID: 19427413
[TBL] [Abstract][Full Text] [Related]
39. The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor.
Ajeganova S; van Steenbergen HW; Verheul MK; Forslind K; Hafström I; Toes RE; Huizinga TW; Svensson B; Trouw LA; van der Helm-van Mil AH
Ann Rheum Dis; 2017 Jan; 76(1):112-118. PubMed ID: 27117699
[TBL] [Abstract][Full Text] [Related]
40. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
van der Woude D; Houwing-Duistermaat JJ; Toes RE; Huizinga TW; Thomson W; Worthington J; van der Helm-van Mil AH; de Vries RR
Arthritis Rheum; 2009 Apr; 60(4):916-23. PubMed ID: 19333951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
